FIELD: medicine.
SUBSTANCE: invention relates to pharmaceutics and medicine, and use of naloxone and naltrexone derivatives in making pain-killing drugs with a central mechanism of action.
EFFECT: developing highly effective drugs which are not addictive.
6 cl, 5 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BUPRENORPHINE-CONTAINING ANALGESIC COMPOSITIONS | 2000 |
|
RU2255737C2 |
| ANALGESIC AGENT FOR VISCERAL PAIN MANAGEMENT | 2010 |
|
RU2429874C1 |
| ANALGETIC PREPARATION | 1992 |
|
RU2077326C1 |
| DIMERIC DIPEPTIDE MIMETIC BDNF AS AGENT FOR TREATING AND PREVENTING OPIOID ADDICTION | 2023 |
|
RU2823374C1 |
| 6-(3,3-DIMETHYL-3,4-DIHYDROISOCHINOLIN-1-IL) AMINOHEXANE ACID AND PHARMACEUTICAL COMPOSITION ON ITS BASIS THAT HAVE ANALGETIC ACTIVITY | 2016 |
|
RU2648445C1 |
| METHOD FOR PREVENTION ABUSE WITH OPIOID- -CONTAINING MEDICINAL FORMULATIONS | 1998 |
|
RU2228180C2 |
| ORGANIC COMPOUNDS | 2018 |
|
RU2780002C2 |
| ORGANIC COMPOUNDS | 2018 |
|
RU2777366C2 |
| APPLICATION OF ANTAGONISTS OF OPIOID RECEPTORS IN CASE OF GASTROINTESTINAL TRACT DISEASES | 2010 |
|
RU2561873C2 |
| SYNTHETIC ANALGESIC AGENT AND METHOD FOR TREATMENT BASED ON THIS AGENT | 2006 |
|
RU2322977C1 |
